| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 03/11/2009 | CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 03/11/2009 | CN100466924C Corrective clothes with liner |
| 03/10/2009 | US7501527 Method for the production of fluoromethyl-substituted heterocycles |
| 03/10/2009 | US7501421 Benzoxazole and benzothiazole derivatives as 5-hydroxytryptamine-6 ligands |
| 03/05/2009 | WO2009027998A2 A process for the preparation of alanine-nca (alanine-n-carboxyanhydride) from alanine with tri phosgene |
| 03/05/2009 | WO2009027450A1 Novel bradykinin b1-antagonists |
| 03/05/2009 | WO2008138591A3 Bicyclic and heterobicyclic derivatives,processes for preparing them and their uses |
| 03/05/2009 | US20090062530 Substituted arylalkanoic acid derivatives and use thereof |
| 03/05/2009 | US20090062527 Process for Preparing Optically Active Alcohols |
| 03/05/2009 | US20090062340 Novel biaromatic compounds which activate ppary type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 03/05/2009 | US20090062286 Crystal Structure of SMYD3 Protein |
| 03/05/2009 | US20090061143 Organic compound for recording layer for high speed recording of information and optical recording medium including the same |
| 03/05/2009 | CA2697946A1 New bradykinin b1-antagonists |
| 03/04/2009 | EP2030974A1 Heterocyclic non-nucleoside compounds, their peparation, pharmaceutical composition and their use as antiviral agents |
| 03/04/2009 | EP2029561A1 Tricyclic compound and pharmaceutical use thereof |
| 03/04/2009 | EP2029560A2 1,3-oxazolidin-2-one derivatives useeful as cetp inhibitors |
| 03/04/2009 | EP1472209B1 Lipoxin a4 analogs |
| 03/04/2009 | CN101379047A Preparation of delmopinol |
| 03/04/2009 | CN101379046A Processes for taxane derivatives and intermediates useful therein |
| 03/04/2009 | CN101379045A Diaromatic amine derivatives as antioxidants |
| 03/04/2009 | CN101379044A Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
| 03/04/2009 | CN100465167C 5-Methyl-2-trifluoromethyl benzoxazole and a synthesizing method thereof |
| 03/04/2009 | CN100465166C 5-Methyl-2-difluoromethyl benzoxazole and a synthesizing method thereof |
| 03/04/2009 | CN100465165C A synthesizing method of chiral oxazolidine-2-thioketone compounds |
| 03/03/2009 | US7498436 Substituted hydroxyethylamines |
| 03/03/2009 | US7498352 TGF-β superfamily production/secretion promoter |
| 02/26/2009 | WO2009025358A1 Heterocyclic compound and use thereof |
| 02/26/2009 | WO2009025265A1 Piperazine derivative |
| 02/26/2009 | US20090054652 Cyanine Compound and Optical Recording Material |
| 02/26/2009 | US20090054479 Fused heterocyclic derivatives as ppar modulators |
| 02/26/2009 | US20090054450 Compositions and methods of use for treating or preventing lipid related disorders |
| 02/26/2009 | US20090054448 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 02/26/2009 | US20090054435 Phenoxyalkanoic Acid Compound |
| 02/26/2009 | US20090054420 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 02/26/2009 | US20090053175 Substitute pyrrolidine derivatives |
| 02/26/2009 | DE102007040243A1 17Beta-Hydroxysteriod-Dehydrogenase Typ1 Inhibitoren zur Behandlung hormonabhängiger Erkrankungen 17beta-dehydrogenase type 1 Hydroxysteriod inhibitors for the treatment of hormone-dependent diseases |
| 02/25/2009 | EP1856031B1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 02/25/2009 | EP1143965B1 Carbocyclic potassium channel inhibitors |
| 02/25/2009 | CN101374824A Heterocyclic GABA-B modulators |
| 02/25/2009 | CN101374813A Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders |
| 02/25/2009 | CN101372481A Method for synthesizing 6-chloro-2-(p-hydroxyl)-phenoxy-benzoxazole |
| 02/25/2009 | CN101372480A Method for synthesizing 2,6-dichlorobenzoxazole |
| 02/24/2009 | US7495109 Nociceptin analogs |
| 02/24/2009 | US7495021 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 02/24/2009 | US7495020 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 02/19/2009 | WO2009023758A1 Heterocyclyl substituted fused carbocyles useful in the treatment of conditions such as glaucoma and pain |
| 02/19/2009 | WO2009023757A1 Therapeutic compounds |
| 02/19/2009 | WO2009021749A2 Preparation of a compound for the treatment of duchenne muscular dystrophy |
| 02/19/2009 | WO2009021748A2 Polymorphs of a compound for the treatment of duchenne muscular dystrophy |
| 02/19/2009 | WO2008106128A3 CYCLIC UREA AND CARBAMATE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1 |
| 02/19/2009 | US20090048441 Process for the Preparation of Ezetimibe |
| 02/19/2009 | US20090048314 Treatment of duchenne muscular dystrophy |
| 02/19/2009 | US20090048311 Compostions and Methods for Controlling Nematodes |
| 02/19/2009 | US20090048255 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 02/19/2009 | US20090047687 Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation |
| 02/19/2009 | US20090045373 Compounds, ionic liquids, molten salts and uses thereof |
| 02/19/2009 | CA2696404A1 Therapeutic compounds |
| 02/19/2009 | CA2696315A1 Heterocyclyl substituted fused carbocyles useful in the treatment of conditions such as glaucoma and pain |
| 02/19/2009 | CA2685939A1 Treatment of duchenne muscular dystrophy |
| 02/19/2009 | CA2685605A1 Treatment of duchenne muscular dystrophy |
| 02/19/2009 | CA2685590A1 Treatment of duchenne muscular dystrophy |
| 02/18/2009 | EP2024348A2 Benzoxazole and benzothiazole derivatives as 5-hydroxytrytamine-6 ligands |
| 02/18/2009 | EP2024347A1 Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments |
| 02/18/2009 | EP2024334A2 Substituted esters as cannabinoid-1 receptor modulators |
| 02/18/2009 | EP1283204B1 Methods for crystallization of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanine n-carboxyanhydride |
| 02/18/2009 | CN101367888A Radical polymerization |
| 02/18/2009 | CN101367773A Bicyclo oxazolidine tanning agent and method of preparing the same |
| 02/17/2009 | US7491833 Valerolactone compounds and perfume composition |
| 02/17/2009 | US7491747 4-(Arylthio)- or (4-heteroarylthio)butyric acid derivatives that may be used in the treatment of dyslipidaemia, atherosclerosis and diabetes |
| 02/17/2009 | US7491718 Aminopeptidase inhibitor; vision defects; administering to eye |
| 02/12/2009 | US20090043116 Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds |
| 02/12/2009 | US20090043096 Method of producing aromatic compound |
| 02/12/2009 | US20090042892 Cetp Inhibitors |
| 02/12/2009 | US20090042885 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 02/12/2009 | US20090042772 Compounds and methods of treating insulin resistance and cardiomyopathy |
| 02/11/2009 | EP2022500A1 Tumor suppressor |
| 02/11/2009 | CN101365689A 1,3-oxazolidin-2-one derivatives useful as cetp inhibitors |
| 02/11/2009 | CN101365681A Iminopropene compound and use thereof |
| 02/11/2009 | CN101362731A Heterocyclic compounds and methods of use |
| 02/10/2009 | US7488829 Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 02/05/2009 | WO2009015877A1 Novel herbicides |
| 02/05/2009 | US20090036677 Preparation of Delmopinol |
| 02/05/2009 | US20090036504 2-Aminoethoxyacetic Acid Derivatives and Their Use |
| 02/05/2009 | US20090036457 Utilities of olefin derivatives |
| 02/05/2009 | US20090036450 Pyrazole compounds and use thereof |
| 02/05/2009 | US20090036438 Five-membered heterocycles useful as serine protease inhibitors |
| 02/05/2009 | US20090036420 Benzamide derivatives and their use for treating cns disorders |
| 02/05/2009 | CA2693190A1 Novel herbicides |
| 02/04/2009 | EP2019822A1 A new process for the synthesis of 2-aminoxazole compounds |
| 02/04/2009 | EP2019674A2 Histone deacetylase and tubulin deacetylase inhibitors |
| 02/04/2009 | EP1492773B1 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |
| 02/04/2009 | CN101360730A Fungicide N-cycloalkyl-benzyl-amide derivatives |
| 02/04/2009 | CN101360705A Amino-alkyl-amide derivatives as CCR3 receptor ligands |
| 02/04/2009 | CN100457753C N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 02/04/2009 | CN100457743C Preparation process of chiral 4-substituent-2-oxazolidone |
| 02/04/2009 | CN100457742C Biaryl heterocyclic compounds and methods of making and using the same |
| 02/03/2009 | US7485722 E.g., 3-(2'-Morpholin-4-ylmethyl-biphenyl-4-ylmethyl)-1-oxa-3-aza-spiro[4.5]decan-2-one; acute and chronic neurological and psychiatric disorders and chronic and acute pain disorders; Alzheimer's disease; schizophrenia; antidepressants; bipolar disorders; antiischemic agents; cardiotonic agents |
| 02/03/2009 | CA2314607C Use of ppar-.gamma. activators in dermatology |
| 01/29/2009 | WO2009015369A2 Isophthalamide derivatives inhibiting beta-secretase activity |
| 01/29/2009 | WO2009015111A2 Process for preparing oxazolidine-and oxazolidinone-aminodiols and related intermediates |